SLC30A3 and Alzheimer disease: Changes in the expression of several zinc transporting proteins have also been reported in studies of postmortem brain tissue from AD cases and models (34), although it is difficult to know whether these changes are, like ZnT3, potentially upstream in the pathological process or whether they represent homeostatic responses.